References
- Sweetman S. Martindale, Guía Completa de Consulta Farmacoterapéutica. 1st Barcelona: Pharma Editores S.L., 2003.
- Alastair JJ, Wood MD. Schizophrenia. New Engl J Med 2003;349(18):1738–49.
- Hardman J, Limbird L. Goodman, Gilman. Las bases farmacológicas de la terapéutica. 10th México: McGraw-Hill, 2003.
- Rosenheck R, Perlick D, Bingham S, . Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia. J Am Med Assoc 2003;290(20):2693–702.
- Patel N, Crismon L, Miller A, Johnsrud M. Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy 2005;25(9):1242–47.
- Rzewuska M. Drug maintenance treatment compliance and its correlation with the clinical picture and course of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(4):811–14.
- Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002;106(4):286–90.
- Loffler W, Killian R, Toumi M, Angermeyer MC. Schizophrenic patients’ subjective reasons for compliance and non-compliance with neuroleptic treatment. Pharmacopsychiatry 2003;36(3):105–12.
- Bradford DW, Perkins DO, Lieberman JA. Pharmacological management of first-episode schizophrenia and related non-affective psychoses. Drugs 2003;63(21):2265–83.
- Davis JM, Chen N. Choice of maintenance medication for schizophrenia. J Clin Psychiatry 2003;64(Suppl 16):24–33.
- Kampman O, Laippala P, Vaanamen J, . Indicators of medication compliance in first-episode psychosis. Psychiatry Res 2002;110(1):39–48.
- Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature on intervention: enhance compliance with antipsychotic medication. Psychiatr Ment Health Nurs 2002;9(3):277–84.
- Marder SR. Overview of partial compliance. J Clin Psychiattry 2003;64(Suppl 16):3–9.
- Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes. A systematic review. Psychol Med 2003;33(7):1149–60.
- Baloush-Kleinman V, Poyurovsky M, Koren D, Schneidman M, Weizman A, Shnitt D. Adherence to antipsychotic medication in schizophrenia patients. Harefuah 2002;141(12): 1042–9, 1090.
- Misdrahi D, Llorca PM, Lancon C, Bayle FJ. Compliance in schizophrenia: predictive factors, therapeutical consideration and research implications. Encephale 2002;28(3 Pt 1): 266–72.
- Perkins DO. Predictors for non-compliance in patients with schizophrenia. J Clin Psychiatry 2002;63(12):1121–28.
- Day J, Bentall R, Robert C, . Attitudes toward antipsychotic medication. The impact of variables and relationships with health professionals. Gen Psychiatry 2005; 62(7):717–24.
- Osterbergs L, Blachske T. Adherence to medication. New Engl J Med 2005;353(5):487–497.
- McEvoy G. AHFS drug information. 48th Bethesda, MD: American Society of Health-System Pharmacists, 2006.
- Mennickent S, Sobarzo A, Vega M, de Diego M, Godoy G, Rioseco P, . Quantitative determination of clozapine in serum by instrumental planar chromatography. J Sep Sci 2007;30(13):2167–72.
- Van der Weide J, Steijns LS, van Weelden MJ. The effect of smoking and cytochrome P 450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. Pharmacogenetics 2003;13(3):169–72.